Heather Raymon, SVP, Research and Development at Artiva Biotherapeutics, Inc. (ARTV), sold 3,095 shares at $9.01 ($28K) on 2026-05-19, disclosed to the SEC on 2026-05-19.
Open-market sale of $28k ARTV by SVP, Research and Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.